Cabio Biotech (Wuhan) Co., Ltd.

SHSE:688089 Stock Report

Market Cap: CN¥3.5b

Cabio Biotech (Wuhan) Valuation

Is 688089 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 688089 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 688089 (CN¥20.74) is trading above our estimate of fair value (CN¥2.14)

Significantly Below Fair Value: 688089 is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 688089?

Key metric: As 688089 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 688089. This is calculated by dividing 688089's market cap by their current earnings.
What is 688089's PE Ratio?
PE Ratio30.4x
EarningsCN¥114.85m
Market CapCN¥3.49b

Price to Earnings Ratio vs Peers

How does 688089's PE Ratio compare to its peers?

The above table shows the PE ratio for 688089 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average40.7x
300239 Baotou Dongbao Bio-TechLtd
35.1xn/aCN¥3.2b
002054 Dymatic ChemicalsInc
63.4xn/aCN¥3.0b
688179 Shanghai Aladdin Biochemical TechnologyLtd
39.2xn/aCN¥4.1b
688267 China Catalyst Holding
25x20.2%CN¥3.7b
688089 Cabio Biotech (Wuhan)
30.4x22.4%CN¥3.5b

Price-To-Earnings vs Peers: 688089 is good value based on its Price-To-Earnings Ratio (30.4x) compared to the peer average (40.7x).

Price to Earnings Ratio vs Industry

How does 688089's PE Ratio compare vs other companies in the CN Chemicals Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No more companies available in this PE range
688089 30.4xIndustry Avg. 35.2xNo. of Companies42PE020406080100+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 688089 is good value based on its Price-To-Earnings Ratio (30.4x) compared to the CN Chemicals industry average (35.2x).

Price to Earnings Ratio vs Fair Ratio

What is 688089's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

688089 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio30.4x
Fair PE Ratio22.7x

Price-To-Earnings vs Fair Ratio: 688089 is expensive based on its Price-To-Earnings Ratio (30.4x) compared to the estimated Fair Price-To-Earnings Ratio (22.7x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 688089 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCN¥20.74
CN¥18.50
-10.8%
8.1%CN¥20.00CN¥17.00n/a2
Nov ’25CN¥20.92
CN¥18.50
-11.6%
8.1%CN¥20.00CN¥17.00n/a2
Oct ’25CN¥20.29
CN¥18.50
-8.8%
8.1%CN¥20.00CN¥17.00n/a2
Sep ’25CN¥15.54
CN¥18.50
+19.0%
8.1%CN¥20.00CN¥17.00n/a2
Aug ’25CN¥15.52
CN¥18.50
+19.2%
8.1%CN¥20.00CN¥17.00n/a2
Jul ’25CN¥13.30
CN¥18.50
+39.1%
8.1%CN¥20.00CN¥17.00n/a2
Jun ’25CN¥15.58
CN¥18.50
+18.7%
8.1%CN¥20.00CN¥17.00n/a2
May ’25CN¥19.65
CN¥18.50
-5.9%
8.1%CN¥20.00CN¥17.00n/a2
Oct ’24CN¥19.57
CN¥36.43
+86.1%
17.6%CN¥42.86CN¥30.00CN¥20.292
Sep ’24CN¥21.03
CN¥36.43
+73.2%
17.6%CN¥42.86CN¥30.00CN¥15.542
Aug ’24CN¥22.05
CN¥35.71
+62.0%
20.0%CN¥42.86CN¥28.57CN¥15.522
Jul ’24CN¥21.29
CN¥35.71
+67.8%
20.0%CN¥42.86CN¥28.57CN¥13.302
Jun ’24CN¥20.33
CN¥35.71
+75.7%
20.0%CN¥42.86CN¥28.57CN¥15.582
May ’24CN¥22.97
CN¥35.71
+55.5%
20.0%CN¥42.86CN¥28.57CN¥19.652
Apr ’24CN¥27.94
CN¥40.36
+44.4%
6.2%CN¥42.86CN¥37.86CN¥15.092
Mar ’24CN¥36.05
CN¥40.36
+11.9%
6.2%CN¥42.86CN¥37.86CN¥13.332

Analyst Forecast: Target price is lower than the current share price.

Discover undervalued companies

Yunnan Yuntianhua

CN¥40.3b

Engages in the phosphate ore mining, chemical fertilizers, engineering materials, agriculture, and trade and logistics businesses in China.

600096

CN¥22.08

7D

-1.3%

1Y

37.5%

Chifeng Jilong Gold MiningLtd

CN¥29.1b

Operates as a gold and non-ferrous metal mining company.

600988

CN¥17.66

7D

2.7%

1Y

31.4%

MeiHua Holdings GroupLtd

CN¥30.1b

A synthetic biology company, provides amino acid nutrition and health solutions in China and internationally.

600873

CN¥10.55

7D

4.6%

1Y

12.2%